Loading...
Loading...
VRAY| Name | Value |
|---|---|
| Revenues | 18.9M |
| Cost of Revenue | 18.8M |
| Gross Profit | 0.1M |
| Operating Expense | 27.6M |
| Operating I/L | -27.5M |
| Other Income/Expense | 1.7M |
| Interest Income | 0.0M |
| Pretax | -25.8M |
| Income Tax Expense | -1.7M |
| Net Income/Loss | -24.1M |
ViewRay, Inc. specializes in designing, manufacturing, and marketing MRI-guided radiation therapy systems for cancer treatment. Their flagship product, MRIdian, is an advanced system that addresses beam distortion and skin toxicity concerns. The company caters to a wide range of healthcare institutions, including research hospitals, community hospitals, private practices, government facilities, and cancer centers. ViewRay, Inc. generates revenue through direct sales and a robust distribution network, allowing them to reach customers both domestically and internationally.
